BIBLIOGRAPHY

Abraham AG, Gange SJ, Rawleigh SB, Glass, LR, Springer G, Samet JM. 2010. Retrospective mortality study among employees occupationally exposed to toner. J Occup Environ Med 52:1035-1041. AGS. 2013. Manufactured nanomaterials, announcement on hazardous substances 527 (BekGS 527).

Committee on Hazardous Substances, Dortmund, Germany. Federal Ministry of Labour and Social Affairs (BMAS), Federal Institute for Occupational Safety and Health (BauA), Berlin, Germany. Joint Ministerial Gazette (GMBl) 25:498-511.

Albrecht C, Schins RP, Höhr D, Becker A, Shi T, Knaapen AM, Borm PJ. 2004. Inflammatory time course after quartz instillation: role of tumour necrosis factor-alpha and particle surface. Am J Respir Cell Mol Biol 31:292-301.

Attfield MD, Morring K. 1992. An investigation into the relationship between coal workers’ pneumoconiosis and dust exposure in U.S. coal miners. Am Ind Hyg Assoc J 53:486-492.

Attfield M, Kuempel ED. 2008. Mortality among US underground coal miners: A 23-year follow-up. Am J Ind Med 51:231-245.

Barlow PG, Brown DM, Donaldson K, MacCallum J, Stone V. 2008. Reduced alveolar macrophage migration induced by acute ambient particle (PM10) exposure. Cell Biol Toxicol 24:243-252.

Bellmann B, Muhle H, Creutzenberg O, Mermelstein R. 1992. Irreversible pulmonary changes induced in rat lung by dust overload. Environ Health Perspect 189-191.

Bermudez E, Mangum JB, Asgharian B, Wong BA, Reverdy EE, Janszen DB, Hext PM, Warheit DB, Everitt JI. 2002. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 70:86-97.

Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77:347-357.

Bernstein D, Castranova V, Donaldson K, Fubini B, Hadley J, Hesterberg T, Kane A, Lai D, McConnell EE, Muhle H, Oberdorster G, Olin S, Warheit DB; ILSI Risk Science Institute Working Group. 2005. Testing of fibrous particles: short-term assays and strategies. Inhal Toxicol 17:497-537.

Bhattacharjee M, Unni BG, Das S, Deka M, Wann SB. 2011. Lung function decline: a cohort study in a population exposed to coal dust. University Guwahati, Assam, India. bgunni@yahoo.com Borm PJ, Tran L. 2002. From quartz hazard to quartz risk: the coal mines revisited. Ann Occup Hyg 46:25-32.

Borm PJ, Schins RP, Albrecht C. 2004. Inhaled particles and lung cancer. Part B: Paradigms and risk assessment. Int. J. Cancer 110: 3-14

Borm PJ, Tran L, Donaldson K. 2011. The carcinogenic action of crystalline silica: a review of the evidence supporting secondary inflammation-driven genotoxicity as a principal mechanism. Crit Rev Toxicol 41:756-770.

Brown JS, Wilson WE, Grant LD. 2005. Dosimetric comparisons of particle deposition and retention in rats and humans. Inhal. Toxicol 17: 355-385

Carrillo JC. 2012. Summary sheet [for evaluation of literature references]. Presented to TF on 14-May-12.

Carter JM, Corson N, Driscoll KE, Elder A, Finkelstein JN, Harkema JN, Gelein R, Wade-Mercer P, Nguyen K, Oberdorster G. 2006. A comparative dose-related response of several key pro- and antiinflammatory mediators in the lungs of rats, mice, and hamsters after subchronic inhalation of carbon black. J Occup Environ Med 48:1265-1278.

Carthew P, Fletcher S, White A, Harries H, Weber K. 2006. Transcriptomic and histopathology changes in rat lung after intratracheal instillation of polymers. Inhal Toxicol 18:227-245.

Castranova V, Vallyathan V. 2000. Silicosis and coal workers' pneumoconiosis. Environ Health Perspect108 S4:675-684.

Chemical Watch. 2011. 2020 is just around the corner for EU toxicology body. Chemical Watch 13-15-April-11

Cherrie JW, Brosseau LM, Hay A, Donaldson K. 2013. Low-toxicity dusts: Current exposure guidelines are not sufficiently protective. Ann Occup Hyg 57:685-691.

Christensen FM, Johnston HJ, Stone V, Aitken RJ, Hankin S, Peters S, Aschberger K. 2010. Nano titanium-dioxide - Feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 5: 110-124

CIIT Centers for Health Research. 2011. Multiple path particle dosimetry , MPPD v. 2.11. A model for human and rat airway particle dosimetry. Chemical Industry Institute of Toxicology, Research Triangle Park, CA, USA. Applied Research Associates, (ARA), Albuquerque, NM, USA. http://www.ara.com/products/mppd.htm

Creutzenberg O, Bellmann B, Korolewitz R, Koch W, Mangelsdorf I, Tillmann T, Schaudien D. 2012. Change in agglomeration status and toxicokinetic fate of various nanoparticles in vivo following lung exposure in rats. Inhal Toxicol 24:821-830.

Creutzenberg OH, Bellmann B, Korolewitz R, Koch W, Mangelsdorf I, Tillmann T, Schaudien D. 2013. Reply to the "Letter to the Editor” by Morfeld et al, Inhal Toxicol 25:65.

Current Intelligence Bulletin 64. 2011. Coal Mine Dust Exposures and Associated Health Outcomes. Department of Health and Human Services.

DFG, ed. 2013. Nanomaterials. Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. 2013. Report Deutsche Forschungsgemeinschaft, Bonn, Germany. Wiley-VCH, Weinheim, Germany. http://onlinelibrary.wiley.com/book/10.1002/9783527673919

Donaldson K. 2000. Nonneoplastic lung responses induced in experimental animals by exposure to poorly soluble nonfibrous particles. Inhal Toxicol 12:121-139

Donaldson K, Poland CA. 2012. Inhaled nanoparticles and lung cancer – what we can learn from conventional particle toxicology. Swiss Med Wkly 142:13547

Donaldson K, Seaton A. 2012. A short history of the toxicology of inhaled particles. Part Fibre Toxicol 9:1-12.

Donaldson K, Poland CA. 2013. Nanotoxicity: challenging the myth of nano-specific toxicity. Curr Opin Biotechnol 1223: 11 pp online. doi:10.1016/j.copbio.

Donaldson K, Borm PJ, Oberdorster G, Pinkerton KE, Stone V, Tran CL. 2008. Concordance between in vitro and in vivo dosimetry in the proinflammatory effects of low-toxicity, low-solubility particles: the key role of the proximal alveolar region. Inhal Toxicol 20:53-62.

Dörger M, Allmeling A, Neuber A, Behr J, Rambeck W, Krombach F. 1997a. Interspecies comparison of rat and hamster alveolar macrophage antioxidative and oxidative capacity. Environ. Health Perspect 105: 1309-1312

Dörger M, Jesch NK, Rieder G, Hiryonen MR, Savolainen K, Krombach F, Messmer K. 1997b. Species differences in nitric oxide formation by rat and hamster alveolar macrophages in vitro. Am J Respir Cell Mol Biol 16: 413-420

Dorn JL. 2010. Metabolism, variability and risk assessment. Toxicology 268: 156-164

Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. 1996. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J9:1736-1742.

Driscoll KE. 2000. TNFα and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett 112-113:177-183.

Driscoll KE, Carter JM, Hassenbein DG, Howard B. 1997. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect 105:1159-1164.

Driscoll KE, Deyo LC, Howard BW, Poynter J, Carter JM. 1995. Characterizing mutagenesis in the hprt gene of rat alveolar epithelial cells. Exp Lung Res 21: 941-956

Driscoll KE, Deyo LC, Carter JM, Howard BW, Hassenbein DG, Bertram TA. 1997. Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. Carcinogenesis18:423-430.

Driscoll KE, Carter JM, Howard BW, Hassenbein DG, Pepelko W, Baggs RB, Oberdörster G. 1996. Pulmonary inflammatory, chemokine, and mutagenic responses in rats after subchronic inhalation of carbon black. Toxicol Appl Pharmacol 136:372-380.

EC. 2012.Commission staff working paper: Types and uses of nanomaterials, including safety aspects. Accompanying the communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee on the second regulatory review on nanomaterials COM(2012) 572 final. Unpublished report SWD(2012) 288 final. European Commission, Brussels, Belgium.

ECETOC 2010. Guidance on assessment factors to derive a DNEL. Technical report 110. European Centre for Ecotoxicology and Toxicology of Chemicals. Brussels.

ECHA. 2011. Mechanisms not relevant to humans. In: Guidance on the application of the CLP criteria. Guidance to Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures. Report ECHA-11-G-06-EN. European Chemicals Agency, Helsinki, Finland, pp 380.

ECHA. 2012a. Advisory note on the consideration of rat lung overload within inhalation toxicity assessment. In Guidance on information requirements and chemical safety assessment. Appendix R7-1 Recommendations for nanomaterials applicable to Chapter R7a Endpoint specific guidance. CARACAL subgroup on nanomaterials. Report ECHA-12-G-03-EN. European Chemicals Agency, Helsinki, Finland, pp 47-50.

ECHA. 2012b. Guidance on information requirements and chemical safety assessment. Appendix R8-15. Recommendations for nanomaterials applicable to Chapter R8 characterization of dose [concentration] response for human health.

ECHA. 2012c. Guidance on information requirements and chemical safety assessment. Part E: Risk characterization.

ECHA. 2012d. Guidance on the application of the CLP criteria. Guidance to Regulation (EC) No 1272/2008 on the classification, labelling and packaging (CLP) of substances and mixtures. Version 3.0 ECHA-12-G-14-EN. European Chemicals Agency, Helsinki, Finland. http://echa.europa.eu/documents/10162/13562/clp_en.pdf

ECHA. 2013. Mechanisms not relevant to humans. In: Guidance on the application of the CLP criteria, Second draft (to generate Version 4.0) for 2nd PEG XXX 201X [16-18 April]. Pratt I, Food Safety Authority of Ireland, Dublin, Ireland. Guidance to Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures. European Chemicals Agency, Helsinki, Finland, pp 424-425.

Elder A, Oberdörster G. 2006. Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med 5:785-796.

Elder A, Gelein R, Finkelstein JN, Driscoll KE, Harkema J, Oberdörster G. 2005. Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci 88:614-629.

Ellender M, Hodgson A, Wood KL, Moody JC. 1992. Effect of bronchopulmonary lavage on lung retention and clearance of particulate material in hamsters. Environ Health Perspet 97: 209-213

Ellis ED, Watkins J, Tankersley W, Phillips J, Girardi D. 2010. Mortality among titanium dioxide workers at three DuPont plants. J Occup Environ Med. 52(3):303-9.

Ellis ED, Watkins JP, Tankersley WG; Phillips JA, Girardi DJ. 2013. Occupational exposure and mortality among workers at three titanium dioxide plants. Am J Ind Med 56:282-291.

Eydner M, Schaudien D, Creutzenberg O, Ernst H, Hansen T, Baumgartner W, Rittinghausen S. 2012. Impacts after inhalation of nano- and fine-sized titanium dioxide particles: morphological changes, translocation within the rat lung, and evaluation of particle deposition using the relative deposition index. Inhal Toxicol 24:557-569.

Ferin J, Feldstein ML. 1978. Pulmonary clearance and hilar lymph node content in rats after particle exposure. Environ Res 16:342-352.

Frans M, Larsen PB. 2013. Information requirements for nanomaterials – IRNANO. The Danish Environmental Protection Agency, Copenhagen, Denmark.

Gallagher J, Sams R, Inmon J, Gelein R, Elder A, Oberdorster G, Prahalad AK. 2003.Formation of 8-oxo-7,8-dihydro-2`-deoxyguanosine in rat lung DNA following subchronic inhalation of carbon black. Toxicol Appl Pharmacol 190: 224-231.

Gebel T. 2012. Small difference in carcinogenic potency between GBP nanomaterials and GBP micromaterials. Arch toxicol 86:995-1007.

Geiser M. 2010. Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulmon Drug Deliv 23: 207-217.

Gonzalez L, Lison D, Kirsch-Volders M. 2008. Genotoxicity of engineered nanomaterials: A critical review. Nanotoxicology 2:252-273.

Green FHY. 2000. Pulmonary responses to inhaled poorly soluble particulate in the human. Inhal. Toxicol 12:59-95.

Gregoratto D, Bailey MR, Marsh JW. 2010. Modelling particle retention in the alveolar-interstitial region of the human lungs. Journal of radiological protection. J Radiol Prot30:491–512.

Gregoratto D, Bailey MR, Marsh JW. 2011. Particle clearance in the alveolar-interstitial region of the human lungs: model validation. Radiat Prot Dosimetry 144:353–356.

Greim H, Borm P, Schins JA, Donaldson K, Driscoll KE, Hartwig A, Kuemperl E, Oberdoerster G, Speit G. 2001. Toxicity of fibers and particles. Workshop report. Inhal Toxicol 13: 101-119.

Groeneveld CN, Hakkert BC, Bos PMJ, de Heer C. 2004. Extrapolation for exposure duration in oral toxicity: A quantitative analysis of historical data. Hum Ecol Risk Assess Int J 10: 709-716.

Gross P, Westrick M. 1954. The permeability of lung parenchyma to particulate matter. Am J Pathol 30:195-213.

Hamilton RF, Wu N, Porter D, Buford M, Wolfarth M, Holian A. 2009. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Particle and fibre toxicology 6:35 doi:10.1186/1743-8977-6-35.

Hassinger C, Sellers K. 2012. What defines nanomaterials? Arcadis Nederland BV, ‘s-Hertogenbosch, Netherlands. Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment; RIVM), Bilthoven, Netherlands. http://www.rivm.nl/bibliotheek/digitaaldepot/What_Defines_Nanomaterials.pdf

Hattis D, Silver K. 1994. Human interindividual variability: A major source of uncertainty in assessing risks for noncancer health effects. Risk Anal 14: 421-431.

Hattis D, Erdreich L, Ballew M. 1987. Human variability in susceptibility to toxic chemical: A preliminary analysis of pharmacokinetic data from normal volunteers. Risk Anal 7: 415-426.

Hattis D, Bairs S, Goble R. 2002. A straw man proposal for quantitative definition of the RfD. Drug Chem Toxicol 25: 403-436.

Hattis D, Banati P, Goble R, Burmaster DE. 1999. Human interindividual variability in parameters related to health risks. Risk Anal 19: 711-726.

Heinrich u, Fuhst R, Rittinghausen R, Creutzenberg O, Bellmann B, Koch W, Leysen K. 1995. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhal Toxicol 7: 533-556.

Hext PM, Tomenson JA, Thompson P. 2005. Titanium dioxide: inhalation toxicology and epidemiology. Ann Occup Hyg 49:461-472.

Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden JG. 2010. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol30:7-36.

Howard MD. 1995. Coal Mine Dust Exposures and Associated Health outcomes. Department of Health and Human Services. Niosh 2011:172.

Huang X. 2011. Iron, Oxidative stress, and cell signalling in the pathogeneses of coal workers' pneumoconiosis, silicosis, and asbestosis. Am J Biomed Sci 3:95-106.

IARC. 2010. Carbon black: Comparison of toxicokinetics and toxicodynamics of inhaled poorly soluble particles in animals and humans. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 93. International Agency for Research on Cancer, Lyon, France, p166-171.

IARC. 2012. Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. Lamia Benbrahim-Tallaa, Robert A Baan, Yann Grosse, Béatrice Lauby-Secretan, Fatiha El Ghissassi, Véronique Bouvard, Neela Guha, Dana Loomis, Kurt Straif. International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France. Lancet Oncology DOI 2045:70280-2.

ICRP. 1994. Human respiratory tract model for radiological protection. In: Smith H (ed) Annals of the ICRP, ICRP Publication No. 66, International Commission on Radiological Protection, Tarrytwon, New York.

IEH. 1999. Approaches to predicting toxicity from occupational exposure to dusts. Institute of Environment and Health, Report R11. Cranfield University, Bedfordshire, UK.

ILSI Risk Science Institute. 2000. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. ILSI Risk Science Institute. Inhal Toxicol 12:1-17.

IPA. 1994. Effect of chemical / physical characteristics of HM on the inflammatory and proliferative response induced in the lung. Cited by MAK, 1999 “Polyacrylsäure, neutralisiert, vernetzt”.

Jackson JH, Gajewski E, Schraufstatter IU, Hyslop PA, Fuciarelli AF, Cochrane CG, Dizdaroglu M. 1988. Damage to the bases in DNA induced by stimulated human neutrophils. J Clin Invest 84: 1644-1649.

Jesch NK, Dörger M, Enders G, Rieder G, Vogelmeier C, Messmer K, Krombach F. 1997. Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: An interspecies comparison. Environ Health Perspect 105: 1297-1300.

Ji JH, Yu IJI. 2012. Estimation of human equivalent exposure from rat inhalation toxicity study of silver nanoparticles using multi-path particle dosimetry model. Toxicol Res 1:206-210.

Johnson DL, Martonen TB. 1994. Predicted and observed behavior of platelet aerosols. Particulate Science and Technology 12:149–159.

Johnston CJ, Driscoll KE, Finkelstein JN, Baggs R, O'Reilly MA, Carter J, Gelein R, Oberdörster G. 2000. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol Sci56:405-413.

Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Stone V. 2009. Particle and fibre toxicology. Part Fibre Toxicol 1743-8977.

Jones AD. 1993. Respirable industrial fibres: deposition, clearance and dissolution in animal models. The Annals of occupational hygien 37:211–26.

Kalberlah F, Foest U, Schneider K. 2002. Time extrapolation and interspecies extrapolation for locally acting substances in case of limited toxicological data. Am Occup Hyg 46: 175-185.

Kalberlah F, Schneider K, Schuhmacher-Wolz U. 2011. Gutachten zur biologischen plausibilität von HEC und MPPD. Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Freiburg, Germany. AGS-Geschäftsführung – BauA. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Dortmund, Germany. http://www.baua.de/de/Themen-von-A-Z/

Kanapilly GM, Diel JH. 1980. Ultrafine 239PuO2 aerosol generation, characterization and short-term inhalation study in the rat. Health Phys 39:505-19.

Klein CL, Wiench K, Wiemann M, Ma-Hock L, van Ravenzwaay B, Landsiedel R. 2012. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol 86:1137-1151.

Klobes P, Meyer K, Munro RG. 2006. Porosity and specific surface area measurements for solid materials. National Institute of Standards and Technology (NIST), Recommended Practice Guide, Special Publication 960-12 U.S. Department of Commerce.

Knaapen AM, Albrecht C, Becker A, Höhr D, Winzer A, Haenen GR, Borm PJ, Schins RP. 2002. DNA damage in lung epithelial cells isolated from rats exposed to quartz: role of surface reactivity and neutrophilic inflammation. Carcinogenesis 23:1111-1120.

Kolling A, Ernst H, Rittinghausen S, Heinrich U. 2011. Relationship of pulmonary toxicity and carcinogenicity of fine and ultrafine granular dusts in a rat bioassay. Inhal Toxicol 23:544-554.

Krueger N. 2012. Lung overload Pauluhn paper. Presented at TF meeting 02-Apr-12.

Krueger N. 2012. Evaluation of the classification of poorly soluble particle (PSP) for carcinogenicity*(according to the criteria of EU (Official Journal of the EU, No L 110 A/ 60, 4.5.93). Draft statement. Evonik, Wolfgang, Germany.

Kreiling R. 2012. Lung overload hypothesis. Presented at TF meeting 02-Apr-12. Kreiling R. 2012. Diagram of the different steps involved in lung overload: Impaired clearance, secondary genotoxicity and tumour development. Presented at TF meeting 16-Aug-12.

Kreyling WG. 1990. Interspecies comparison of lung clearance of insoluble particles. J Aerosol Med 3: 93-110

Kreyling WG, Dirscherl P, Ferron GA, Heilmann P, Josten M, Miaskowski U, Neuner M, Reitmeir P, Ruprecht L, Schumann G, Takenaka S, Ziesenis A, Heyder J. 1999. Health effects of sulfur-related environmental air pollution. III. Nonspecific respiratory defense capacities. Inhal Toxicol 11:391-422.

Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A65:1513-1530.

Krombach F, Münzing S, Allmelig A, Gerlach J, Behr J, Dörger M. 1997. Cell size of alveolar macrophages: An interspecies comparison. Env Health Perspec 105: 1261-1263.

Kuehl PJ, Anderson TL, Candalaria G, Gershman B, Harlin K, Hesterman JY, Holmes T, Hoppin J, Lackas C, Norenberg JP, Yu H, McDonald JD. 2012. Regional particle size dependent deposition of inhaled aerosols in rats and mice, Inhal Toxicol 24:27-35.

Kuempel ED. 2012. Benchmark approaches to classifying nanomaterials. Presented at Safe Nano Design Workshop, College of Nanoscale Science & Engineering (CNSE), University at Albany, State University of New York, USA. Nanotechnology Research Center (NTRC), National Institute for Occupational Safety and Health (NIOSH), Washington DC, USA.

Kuempel ED, Tran CL, Smith RJ, Bailer AJ. 2001b. A biomathematical model of particle clearance and retention in the lungs of coal miners. II. Evaluation of variability and uncertainty. Regul toxicol pharmacol 34:88–101.

Kuempel ED, Smith RJ, Dankovic DA, Stayner LT. 2008. Rat- and human-based risk estimates of lung cancer from occupational exposure to poorly-soluble particles: a quantitative evaluation. J Phys Conf Ser 151:1742-6596.

Kuempel ED, O`Flaherty EJ, Stayner LT, Attfield MD, Green FHY, Yallyathan V. 1997. Relationship between lung dust burden, pathology and lifetime exposure in an autopsy study of US coal miners. Ann Occup Hyg 41: 384-389.

Kuempel ED, O'Flaherty EJ, Stayner LT, Smith RJ, Green FH, Vallyathan V. 2001a. A biomathematical model of particle clearance and retention in the lungs of coal miners. Regul toxicol pharmacol 34:69–87.

Lam CF, Caterina P, Filion P, van Heerden PV, Ilett KF. 2002. The ratio of polymorphonuclear leucocytes (PMN) to non-PMN cells – A novel method of assessing acute lung inflammation. Exp Toxicol Pathol 54:187-191.

Landsiedel R, Fabian E, Ma-Hock L, van Ravenzwaay B, Wohlleben W, Wiench K, Oesch F. 2012. Toxico-/biokinetics of nanomaterials. Arch Toxicol 86:1021-1060.

Laskin DL. 2009. Macrophages and inflammatory mediators in chemical toxicity: A battle of forces. Chem Res Toxicol 22: 1376-1385.

Laskin DL, Sunil VR, Gardner CR, Laskin JD. 2011. Macrophages and Tissue Injury: Agents of defense or destruction. Annu Rev Pharmacol Toxicol 51: 267-288.

Lauweryns JM, Baert JH. 1974. The role of the pulmonary lymphatics in the defenses of the distal lung: morphological and experimental studies of the transport mechanisms of intratracheally instillated particles. Ann N Y Acad Sci 221:244-275.

LeBuf RF, Stefaniak AB, Chen BT, Frazer DG, Virji MA. 2011. Measurement of airborne nanoparticle surface area using a filter-based gas adsorption method for inhalation toxicology experiments. Nanotoxicology 5:687-699.

Lee KP, Trochimowicz HJ, Reinhardt CF. 1985. Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for two years. Toxicol Appl Pharmacol 79: 179-182.

Lehnert BE, Valdez YE, Tietjen GL. 1989. Aleveolar macrophage-particle relationships during lung clearance. Am J Respir Cell Mol Biol 1: 145-154.

Levy LS. 1995. Review: The 'Particle Overload' phenomenon and human risk assessment. Indoor and Built Environment 4:254-262.

Liu Q, Ma X, Zachariah MR. 2012. Combined on-line differential mobility and particle mass analysis for determination of size resolved particle density and microstructure evolution. Microporous and Mesoporous Mater 153:210–216.

Ma Hock L. 2012. Decision tree [on biosolubility of particles]. Presented to TF on 06-Nov-12.

MAK. 2012a. MAK-Begründung allgemeiner Staubgrenzwert (A-Fraktion) – Granuläre biobeständige Stäube (GBS), Nachtrag 2012. DFG Senatskommisssion zur Prüfung Gesundheitschädlicher Arbeitsstoffe, Karlsruhe, Germany, 53. Lieferung .

MAK. 2012b. Working translation [Kreiling R], original: German. Assessment. [MAK document concerning the derivation of 0.3 mg/m3 as value for the respirable fraction of "non/low toxic PSP [MAK, 2011a].

Martinez FO, Sica A, Mantovani A, Locati M. 2008. Macrophage activation and polarization. Front Biosci 13: 453-461.

Mattenklott M, Möhlmann C. 2011. Probenahme und analytische Bestimmung von granulären biobeständigen Stäuben (GBS). Gefahrstoffe - Reinhaltung der Luft 71:425-428.

Mauderly JL. 1996. Usefulness of animal models for predicting human responses to long-term inhalation of particles. Chest 109:65S-68S.

McClellan RO. 1997. Use of mechanistic data in assessing human risks from exposure to particles. Environ Health Perspect 105:1363-1372.

McGrath JJ, Purkiss LQ, Eberle M, McGrath WR. 1995. Long-term effects of a cross-linked polyacrylate superabsorbent in the hamster. J Appl Toxicol 15:69-73.

Méndez LB, Gookin G, Phalen RF. 2010. Inhaled aerosol particle dosimetry in mice: A review. Inhal Toxicol 22:1032-1037.

Mermelstein R, Kilpper RW, Morrow PE, Muhle H. 1994. Lung overload, dosimetry of lung fibrosis and their implications to the respiratory dust standard. Ann Occup Hyg 1:313-322.

Meyer EC, Dominguez EA, Bensch KG. 1969. Pulmonary lymphatic and blood absorption of albumin from alveoli. A quantitative comparison. Lab Invest 20:1-8.

Miller BE, Hook ER. 1990. Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants. Environ Health Perspec 85: 15-23.

Miller FJ. 2000. Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: A critical review. Inhal Toxicol 12:19-57.

Mohr U, Ernst H, Roller M, Pott F. 2006. Pulmonary tumour types induced in Wistar rats of the so-called 19-dust study. Exp Toxicol Pathol 58:13–20.

Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K. 2007. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: The role of surface area. Occup Environ Med 64:609-615.

Morfeld P, Emmerich M, Lampert K, Reischig HL, Klinkner H-G, Stegmaier C, Ziegler H, Piekarski C. 2007. Mortalität und Krebsmorbidität Saarländischer Steinkohlenbergleute, 1980-2002. Presented at Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin, 47. wissenshaftliche Jahrestagung, 21-24 März, Mainz, Germany.

Morfeld P, Treumann S, Ma-Hock L, Bruch J, Landsiedel R. 2012. Deposition behavior of inhaled nanostructured TiO2 in rats: fractions of particle diameter below 100 nm (nanoscale) and the slicing bias of transmission electron microscopy. Inhal Toxicol 24:939-951.

Morfeld P, Treumann S, Ma-Hock L, Landsiedel R. 2013. Particle diameter estimates of Creutzenberg et al, are distorted due to the slicing bias of transmission electron microscopy. Letter to the editor. Inhal Toxicol 25:63-64.

Morrow PE. 1988. Possible mechanisms to explain dust overloading of the lungs. Fundam Appl Toxicol 10:369-384.

Morrow PE. 1992. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 113:1-12.

Morrow PE, Haseman JK, Hobbs CH, Driscoll KE, Vu V, Oberdörster G. 1996. The maximum tolerated dose for inhalation bioassays: toxicity vs overload. Fundam Appl Toxicol29:155-167.

Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Ummunol 8: 958-969 Mossman BT. 2000. Mechanisms of action of poorly soluble particulates in overload-related lung pathology. Inhal Toxicol 12:141-148.

Muhle H, Bellmann B, Heinrich U. 1988. Overloading of lung clearance during chronic exposure of experimental animals to particles. Ann Occup Hyg 32: 141-147.

Muhle H, Creutzenberg O, Bellman B, Heinrich U, Mermelstein R. 1990. Dust overloading of lungs: Investigations of various materials, species differences, and irreversibility of effects. J Aerosol Med 3:S111-S128.

Muhle H, Mangelsdorf I. 2003. Inhalation toxicity of mineral particles: critical appraisal of endpoints and study design. Toxicol Lett 11:140-141:223-228.

Murray PJ, Wynn TA. 2011. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723-737.

Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB. 2003. Evaluation of Cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) Immunohistochemistry and In Situ Hybridization of Histone mRNA. J Histochem Cytochem 51:1681-1688.

Nakanishi J. 2011. Risk assessment of manufactured nanomaterials - Overview of approaches and results. Technology Development Organization (NEDO) project (P06041). http://www.aist-riss.jp/main/?ml_lang=en

Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nano level. Science 311: 622-627.

Nemmar A, Holme JA, Rosas I, Schwarze PE, Alfaro-Moreno E. 2013. Recent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studies. Biomed Res Int 279371:1-22.

Ng SP, Warheit DB. 2013. Development of alternative in vitro methods to screen for pulmonary toxicities – Characterization of epithelial- macrophage co-culture and in vitro assay conditions at the air-liquid interface (ALI). Toxicologist 132:314 (Abstract).

Nikula KJ. 2000. Rat lung tumours induced by exposure to selected poorly soluble nonfibrous particles. Inhal Toxicol 12:97-119.

Nikula KJ, Avila KJ, Griffith WC, Mauderly JL. 1997.

Lung tissue responses and sites of particle retention differ between rats and cynomolgus monkeys exposed chronically to diesel exhaust and coal dust. Fundam Appl Toxicol 37:37-53.

Nikula KJ, Vallyathan V, Green FH, Hahn FF. 2001. Influence of exposure concentrations or dose on the distribution of particulate material in rat and human lungs. Environ. Health Perspect 109: 311-318.

NIOSH. 2011. Occupational exposure to titanium dioxide. Current Intelligence Bulletin 63:1-119.

Oberdörster G. 1995. Lung particle overload: Implications for occupational exposures to particles. Regul Toxicol Pharmacol 27:123-135.

Oberdörster G. 1997. Pulmonary carcinogenicity of inhaled particles and the maximum tolerated dose. Environ Health Perspect 105:1347-1355.

Oberdörster G. 2001. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health74:1-8.

Oberdörster G. 2009. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 1365-2796.

Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. 1992. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 97:193-199.

Oberdörster G, Ferin J, Lehnert BE. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 5:173-179.

Oberdörster, G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder AC. 2000. HEI research report: Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 96:5-74.

Boston, MA: Health Effects Institute. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. 2002. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 65:1531-1543.

Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 6:2:1-35.

OECD. 2013. Guidance document on developing and assessing adverse outcome pathways. Series on Testing and Assessment No 184. Paris 2013.

Park K, Kittelson DB, Zachariah MR, McMurry PH. 2004. Measurement of inherent material density of nanoparticle agglomerates. J Nanopart Res 6:267–272.

Pauluhn J. 2009. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminium oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci 109:152-167.

Pauluhn J. 2009. Retrospective analysis of 4-week inhalation studies in rats with focus on fate and pulmonary toxicity of two nanosized aluminum oxyhydroxides (boehmite) and pigment-grade iron oxide (magnetite): The key metric of dose is particle mass and not particle surface area. Toxicol 259:140-148.

Pauluhn J. 2010. Multi-walled carbon nanotubes (Baytubes): approach for derivation of occupational exposure limit. Regul Toxicol Pharmacol 57:78-89.

Pauluhn J. 2011. Common mechanism-based study design for inhalation toxicity testing of poorly soluble (nano-/ultrafine-) particles: are new testing strategies and interpretation guidelines needed? Nanocon.

Pauluhn J. 2011. Interrelating the acute and chronic mode of action of inhaled methylenediphenyl diisocyanate (MDI) in rats assisted by computational toxicology. Regul Toxicol Pharmacol 61:351-364.

Pauluhn J. 2011. Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicol 11:279:176-188.

Pauluhn J, Wiemann M. 2011. Siderite (FeCO₃) and magnetite (Fe₃O₄) overload-dependent pulmonary toxicity is determined by the poorly soluble particle not the iron content. Inhal Toxicol 23:763-783.<pdf>

Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. 1997. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 155: 1376-1383.

Petry T. 2009. Issues related to the application of the GHS STOT criteria to poorly water soluble inorganic particulates of low toxicity. Toxminds, Eurometaux, Brussels, Belgium.

Phalen RF, Mendez LB. 2009. Dosimetry considerations for animal aerosol inhalation studies. Biomarkers 1:63-66.

Phalen RE, Mendez LB, Oldham MJ. 2010. New developments in aerosol dosimetry, Inhalation Toxicol 22:6-14.

Porcheray F, Viaud S, Rimanio AC, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G. 2005. Macrophage activation switching: An asset for the resolution of inflammation. Clin Exp Immunol 142: 481-489.

Porter DW, Hubbs AF, Mercer R, Robinson VA, Ramsey D, McLaurin J, Khan A, Battelli L, Brumbaugh K, Teass A, Castranova V. 2004. Progression of lung inflammation and damage in rats after cessation of silica inhalation. Toxicol Sci 79:370-380.

Pott F, Roller M. 2003. Untersuchungen zur Kanzerogenität granulärer Stäube an Ratten – Ergebnisse und Interpretationen. [Carcinogenicity studies of granular dusts in rats - results and interpretations.] Project number: F 1843, 1. edition. Report with abstract in English. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Dortmund, Germany.

Pott F, Roller M. 2005. Carcinogenicity study with nineteen granular dusts in rats. Eur. J Oncol 10:249–281.

Pratten MK, Lloyd JB. 1986. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biophys Acta 881:307-313.

Pulichino AM, Wang IM, Caron A, Mortimer J, Auger A, Boie Y, Elias JA, Kartono A, Xu L, Menetski J, Sayegh CE. 2008. Identification of transforming growth factor ß1-driven genetic programs of acute lung fibrosis. Am J Respir Cell Mol Biol 39: 324-336.

Raabe OG, A-Bayati MA, Teague SV, Rasolt A. 1988. Regional deposition of inhaled coarse and fine particles in small laboratory animals. Ann Occup Hyg 32:53-63.

Raaschou-Nielsen O, Andersen ZJ, Beelen R, Samoli E, Stafoggia M, Weinmayr G, Hoffmann B, Fischer P, Nieuwenhuijsen MJ, Brunekreef B, Xun WW, Katsouyanni K, Dimakopoulou K, Sommar J, Forsberg B, Modig L, Oudin A, Oftedal B, Schwarze PE, Nafstad P, De Faire U, Pedersen NL, Ostenson CG, Fratiglioni L, Penell J, Korek M, Pershagen G, Eriksen KT, Sørensen M, Tjønneland A, Ellermann T, Eeftens M, Peeters PH, Meliefste K, Wang M, Bueno-de-Mesquita B, Key TJ, de Hoogh K, Concin H, Nagel G, Vilier A, Grioni S, Krogh V, Tsai MY, Ricceri F, Sacerdote C, Galassi C, Migliore E, Ranzi A, Cesaroni G, Badaloni C, Forastiere F, Tamayo I, Amiano P, Dorronsoro M, Trichopoulou A, Bamia C, Vineis P, Hoek G. 2013. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). http/:www.thelancet.com/neurology

Rehn B, Seiler F, Rehn S, Bruch J, Maier M. 2003. Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: untreated and surface treated. Toxicol Appl Pharmacol 189:84-95.

Renne R, Brix A, Harkem J, Herbert R, Kittel B, Lewis D, March T, Nagano K, Pino M, Rittinghausen S, Rosenbruch M, Tellier P, Wohrmann T. 2009. Proliferative and nonproliferative lesions of the rat and mouse respiratory tract. Toxicol Pathol 37: 5S-73S.

Renwick AG, Lazarus NR. 1998. Human variability and noncancer risk assessment - An analysis of the default uncertainty factor. Regul Toxicol Pharmacol 27: 3-20.

Risom L, Moller P, Loft S. 2005. Oxidative stress-induced DNA damage by particulate air pollution. Mut Res 592: 119-137.

Roller M. 2007. Differences between the data bases, statistical analyses, and interpretations of lung tumours of the 19-dust study: two controversial views. Exp Toxicol Pathol 58:393–405.

Roller M. 2008. Research on the carcinogenicity of nanoparticles and other dusts. (Untersuchungen zur krebserzeugenden Wirkung von Nanopartikeln und anderen Stäuben. [text in German]); Research Project No. 2083; ISBN 978-3-88261-069-7.

BauA Dortmund Germany. Roller M. 2009. Carcinogenicity of inhaled nanoparticles. Inhal Toxicol 21: 144-157.

Rushton EK, Jiang J, Leonard SS., Eberlx S, Castranova V, Biswas P, Elder A, Han X, Gelein R, Finkelstein J, Oberdörster G. 2010. Concept of assessing nanoparticle hazards considering nanoparticle dosimetric and chemical/biological response metrics. J Toxicol Environ Health, Part A 73:4454-4461.

Sager TM. 2008. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: Role of particle surface area. Particle Fibre Toxicol 5: 1-17.

Sager TM, Castranova V. 2009. Surface area of particle administered versus mass in detecting the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre Toxicol 6:15:1743-8977.

Santonen T, Stockmann‐Juvala H, Zitting A. 2010. Review on toxicity of stainless steel. Finnish Institute of Occupational Health 52.

Sayes CM, Reed KL, Warheit DB. 2007. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163-180.

Sayes CM, Reed KL, Subramoney S, Abrams L, and Warheit DB. 2009a. Can in vitro assays substitute for in vivo studies in assessing the pulmonary hazards of fine and nanoscale materials? J Nanopart Res 11: 421-431.

Sayes CM, Reed KL, Glover KP, Swain KA, Ostraat ML, Donner EM, Warheit DB. 2010. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolised amorphous silica nanoparticles. Inhal Toxicol 22:348-354.

Scins RP, Knaapen AM. 2007. Genotoxicity of poorly soluble particles. Inhal Toxicol 19: 189-198.

Schins RP, Duffin R, Höhr D, Knaapen AM, Shi T, Weishaupt C, Stone V, Donaldson K, Borm PJ. 2002. Surface modification of quartz inhibits toxicity, particle uptake, and oxidative DNA damage in human lung epithelial cells. Chem Res Toxicol 15:1166-1173.

Schinwald A, Murphy FA, Jones A, MacNee W, Donaldson K. 2012. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS nano 6:736-746.

Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167: 1358-1363.

SCOEL. 2009. Methodology for the derivation of occupational exposure limits: Key documentation (version 6).

Seagrave JC, McDonal JD, Mauderly JL. 2005. In vitro versus in vivo exposure to combustion emissions. Exp Toxicol Pathol 57: 233-238.

Seiler F, Rehn B, Rehn S, Bruchs J. 2001. Significant differences in the cellular and molecular reactions of rat and hamster lung after quartz exposure. Toxicol Lett 119:11-19.

Sies H. 1991. Oxidative stress II. In: Oxidants and antioxidants. London. Academic Press.

Singh N, Manshian B, Jenkins GJ, Griffiths SM, Williams PM, Maffeis TG, Wright CJ, Doak SH. 2009. NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials 30: 3891-3914.

Snipes MB. 1989. Long-term retention and clearance of particles inhaled by mammalian species. Crit Rev Toxicol 20: 175-211.

Stayner LT, Graber JM. 2011. Does exposure to coal dust prevent or cause lung cancer? Occup Environ Med 68(3):167-8.

Stout RD, Suttles J. 2004. Functional plasticity of macrophages reversible adaptations to changing microenvironments. J Leukoc Biol 76: 509-513.

Sweeney LM, Parker A, Haber LT, Tran CL, Kuempel ED. 2013. Application of Markov chain Monte Carlo analysis to biomathematical modeling of respirable dust in US and UK coal miners. Regul Toxicol Pharmacol 66:47-58.

Tran CL, Buchanan D. 2000. Development of a Biomathematical Lung Model to Describe the Exposure-dose Relationship for Inhaled Dust Among U.K. Coal Miners. Edinburgh 41.

Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. 2000. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 12:1113-1126.

UN Secretariat. 2009. Provisional agenda for the seventeenth session, Geneva, 29 June - 1 July 2009. Committee of Experts on the Transport of Dangerous Goods and on the Globally Harmonised System of Classification and Labelling of Chemicals, Sub-Committee of Experts on the Globally Harmonised System of Classification and Labelling of Chemicals, Seventeenth session. Document ST/SG/AC.10/C.4/33/Add.1 17 April 2009. United Nations, Geneva, Switzerland.

UN SCEGHS. 2009. Proposal for the review of Chapter 3.9.2 to avoid scientifically unjustified classification of poorly soluble particles for specific target organ toxicity following repeated exposure on the basis of lung-overload related inflammation responses in the rat. Report ST/SG/AC.10/C.4/2009/5. International Council on Mining and Metals (ICMM) and the European Chemical Industry Council (CEFIC). Committee of Experts on the Transport of Dangerous Goods and on the Globally Harmonised System of Classification and Labelling of Chemicals, Sub-Committee of Experts on the Globally Harmonised System of Classification and Labelling of Chemicals, Seventeenth session, Geneva, 29 June - 1 July 2009. United Nations, Secretariat, Geneva, Switzerland.

Valberg PA, Bruch J, McCunney RJ. 2009. Are rat results from intratracheal instillation of 19 granular dusts a reliable basis for predicting cancer risk? Regul Toxicol Pharmacol 54:72-83.

van Ravenzwaay B, Landsiedel R, Fabian E, Burkhardt S, Strauss V, Ma-Hock L. 2009. Comparing fate and effects of three particles of different surface properties: nano-TiO(2), pigmentary TiO(2) and quartz. Toxicol Lett 186:152-159.

Vermeire T, Stevenson H, Pieters MN, Rennen M, Slob W, Hakkert B. 1999. Assessment factors for human health risk assessment: A discussion paper. Crit Rec Toxicol 29: 439-490.

Warheit DB. 2013. How to measure hazards/risks following exposures to nanoscale or pigment-grade titanium dioxide particles. Toxicol Lett. http://dx.doi.org/10.1016/j.toxlet.2013.04.002.

Warheit DB. 2013. How to measure hazards/risks following exposures to nanoscale or pigment-grade titanium dioxide particles. Toxicol Letters 220: 193-204.

Warheit DB, Webb TR, Reed KL. 2006. Pulmonary toxicity screening studies in male rats with TiO2 particulates substantially encapsulated with pyrogenically deposited, amorphous silica. Part Fibre Toxicol 26:3:3.

Warheit DB, Sayes CM, Reed KL. 2009b. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures? Environ Sci Technol 43:7939-7945.

Weitzmann SA, Gordon LI. 1990. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. J Am Soc Hematol 76: 655-663.

Wiemann M. 2010. Lung overload: a reappraisal of a widely accepted concept. Unpublished report. Institute for Lung Health (IBE R&D), Münster, Germany.

Wynn TA, Barron L. 2010. Macrophages: Master regulators of inflammation and fibrosis. Sem Liver Dis 30: 245-257.

Yamano Y, Kagawa J, Hanaoka T, Takahashi T, Kasai H, Tsugane S, Watanabe S. 1995. Oxidative DNA damage induced by silica in vivo. Environ Res 69: 102-107.

Yokohira M, Kuno T, Yamakawa K, Hosokawa K, Matsuda Y, Hashimoto N, Suzuki S, Saoo K, Imaida K. 2008. Lung toxicity of 16 fine particles on intratracheal instillation in a bioassay model using F344 male rats. Toxicol Pathol 36:620-631.

Yokohira M, Kuno T, Yamakawa K, Hashimoto N, Ninomiya F, Suzuki S, Saoo K, Imaida K. 2009. An intratracheal instillation bioassay system for detection of lung toxicity due to fine particles in F344 rats. J Toxicol Pathol 22:1-10.

Yu RC, Rappaport SM. 1996. Relation between pulmonary clearance and particle burden: a Michaelis-Menten-like kinetic model. Occup Environ Med 53:567-572.

Ziemann C, Rittinghausen S, Ernst H, Kolling A, Mangelsdorf I, Creutzenberg O. 2011. Genotoxic mode of action of fine and ultrafine dusts in lungs. Research Project F 2135. Federal Institute for Occupational Safety and Health (BAuA).